✦ LIBER ✦

Novozymes Jan-Sep 2011: satisfactory 9 months sales and earnings development with strong free cash flow

Book ID: 114373406
Publisher: Elsevier Science
Year: 2011
Weight: 50 KB
Volume: 2011
Category: Article
ISSN: 1351-4180
DOI: 10.1016/s1351-4180(11)70508-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Novozymes Jan-Sep 2010: increased full-y

Novozymes Jan-Sep 2010: increased full-year 2010 expectations after strong 9 month sales and earnings performance

📂 Article 📅 2010 🏛 Elsevier Science ⚖ 53 KB

## Lummus-BP license deal BP has granted Lummus Technology the exclusive licensing and marketing rights to its paraxylene recovery and isomerization process and catalysts. Lummus will handle all sales, marketing and licensing activities.